Výsledky vyhledávání - "Richard Češka"

Notes on the new#8220;Recommendations for the treatment of dyslipidemia. Influencing of lipids to reduce cardiovascular risk#8221

Autor: Richard, Češka

Publikováno v: Vnitrni lekarstvi. 65(12)

New guidelines on dyslipidemia (DLP) related problems appear earlier than planned. Primarily in view of the results of science and large clinical studies, but also with regard to the advent of biological therapy (PCSK9-i) in many Euro-pean countries.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::da1732bea821b4cb72154f6353ba390c
https://pubmed.ncbi.nlm.nih.gov/32013517

Zobrazit plný text záznamu

[Hyperlipoprotienemias and (not only) atherosclerosis: fragments from history and present]

Autor: Richard, Češka

Publikováno v: Casopis lekaru ceskych. 156(6)

The examples from the history, as well as the recent view, clearly demonstrate a great change in the perception of hyperlipoprotienemias and dyslipidemias (HLP and DLP) at the end of 20th and at the beginning of 21st century. Our aim is not a complex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c56335ef3ec3dee66f93ab81fea50bd9
https://pubmed.ncbi.nlm.nih.gov/29212334

Zobrazit plný text záznamu

[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment]

Autor: Richard, Češka, Tomáš, Štulc, Lucie, Votavová, Lucie, Schwarzová, Martina, Vaclová, Tomáš, Freiberger

Publikováno v: Vnitrni lekarstvi. 62(11)

Hyperlipoproteinemia (HLP) and dyslipidemia (DLP) are of course mainly perceived as diseases of common incidence and are typically seen as the greatest risk factors (RF) in the context of the pandemic of cardiovascular diseases. This is certainly tru

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e12e533b6b3ba322e69b87fbdef4ac99
https://pubmed.ncbi.nlm.nih.gov/28128575

Zobrazit plný text záznamu

[Familial hypercholesterolemia in the Czech Republic in 2016]

Autor: Tomáš, Freiberger, Martina, Vaclová, Lukáš, Tichý, Vladimír, Soška, Vladimír, Bláha, Lenka, Fajkusová, Richard, Češka, Michal, Vrablík

Publikováno v: Vnitrni lekarstvi. 62(11)

Familial hypercholesterolemia (FH) is the most frequent autosomal dominant hereditary disease which is characterized by a decreased LDL-cholesterol catabolism and early clinical manifestation of atherosclerosis affecting blood vessels. The MedPed (Ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7917fe615f45222adc383a5f6bb9f854
https://pubmed.ncbi.nlm.nih.gov/28128581

Zobrazit plný text záznamu

[Severe familial hypercholesterolemia treatment]

Autor: Michal, Vrablík, Tomáš, Freiberger, Vladimír, Bláha, Richard, Češka

Publikováno v: Vnitrni lekarstvi. 62(11)

Familial hypercholesterolemia (FH) represents the most frequent of inborn errors of metabolism. It is a group of disorders with a codominant mode of inheritance characterized by marked elevations of LDL-cholesterol as well as atherosclerotic cardiova

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ec744b0645204d76af43b6c25f2808b2
https://pubmed.ncbi.nlm.nih.gov/28128576

Zobrazit plný text záznamu

Akademický článek

Regional differences in physicians’ behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study

Autor: Maciej Banach, Joanna Lewek, Kaja Pol, Daniel Rabczenko, Serban M. Balanescu, Vladimir Blaha, Richard Ceska, Piotr Jankowski, Stanisław Surma, Genovefa Kolovou, Evangelos Liberopoulos, Florin Mitu, Magda Mitu, Franjo Husam Naji, Gyorgy Paragh, Magdalena Popławska, Michal Vrablik, Daniel Pella

Publikováno v: Frontiers in Cardiovascular Medicine, Vol 10 (2023)

BackgroundDespite better accessibility of the effective lipid-lowering therapies, only about 20% of patients at very high cardiovascular risk achieve the low-density lipoprotein cholesterol (LDL-C) goals. There is a large disparity between European c

Externí odkaz: https://doaj.org/article/1165775fe6cd432e8cc922e6c33f441e

Zobrazit plný text záznamu

[Estimating the prevalence of potential drug interactions in patients treated with 5 and more drugs in the Czech Republic and Slovac Repuplic]

Autor: Richard, Češka, Ivan, Tkáč

Publikováno v: Vnitrni lekarstvi. 62(7-8)

Polypragmasy is currently a growing phenomenon, leading to an increased risk of drug interactions. Empirical data to document this trend can only be obtained through a field survey, which, however, is missing in both Czechia and Slovakia. Therefore a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b63a77c369cf724d9fbc95b6d6ba78ae
https://pubmed.ncbi.nlm.nih.gov/27627072

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání